Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

Craniopharyngioma, Child Clinical Trial

Official title: Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

Status Enrolling by invitation

Clinical Trial Summary

New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.

Clinical Trial Description

Current treatment regimens for pediatric CPA are limited to surgery and radiation therapy. This pilot study seeks to identify biologically rational therapeutics for the medical treatment of adamantinomatous CPA by confirming the overexpression of specific molecules. ;

Related Conditions & MeSH terms

• Craniopharyngioma
• Craniopharyngioma, Child

• NCT number: NCT03610906
• Study type: Observational
• Source: University of Colorado, Denver
• Status: Enrolling by invitation
• Start date: March 12, 2019
• Completion date: December 2030